Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.35 |
| ▸ | PGK1 | P00558 | 1/20 | 0.34 |
| ▸ | PGK2 | P07205 | 1/20 | 0.34 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.34 |
| ▸ | HTR3B | O95264 | 2/20 | 0.34 |
| ▸ | HTR3A | P46098 | 2/20 | 0.34 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.34 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitrapyrin SCHEMBL4115039 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHRNFE2L2GAAALDH1A1 | |
| Nitrapyrin SCHEMBL41442 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHRNFE2L2GAAALDH1A1 | |
| Nitrapyrin SCHEMBL21758631 | 0.98 | CYP3A4 (0.95) | CYP3A4TSHRNFE2L2GAAALDH1A1 | |
| Nitrapyrin SCHEMBL9644890 | 0.88 | CYP3A4 (0.77) | CYP3A4TSHRNFE2L2GAAALDH1A1 | |
| Nitrapyrin SCHEMBL18065800 | 0.88 | TSHR (0.77) | CYP3A4TSHRNFE2L2GAAALDH1A1 | |
| Nitrapyrin SCHEMBL30415064 | 0.84 | TSHR (0.71) | CYP3A4TSHRNFE2L2GAAALDH1A1 | |
| SCHEMBL3297356 | 0.84 | TSHR (0.71) | CYP3A4TSHRALDH1A1PGK1PGK2 | |
| SCHEMBL17141418 | 0.81 | CYP3A4 (0.68) | CYP3A4TSHRNFE2L2ALDH1A1PGK1 | |
| SCHEMBL17141411 | 0.81 | CYP3A4 (0.68) | CYP3A4TSHRNFE2L2ALDH1A1PGK1 | |
| SCHEMBL11391263 | 0.79 | CYP3A4 (0.64) | CYP3A4TSHRNFE2L2GAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070479-A | Ultrasonic indicating device and method for monitoring ultrasonic treatment | JP实验室股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-121044944-B | Preparation method of intelligent controlled-release microcapsule of nitrification inhibitor | 吉林农业大学 | 2026-02-27 | — | — | CN | claimed |
| US-20250326839-A1 | TREATMENT OF DISEASES RELATED TO COLONY-STIMULATING FACTOR 1 RECEPTOR DYSFUNCTION USING TREM2 AGONISTS | VIGIL NEUROSCIENCE INC (US) | 2025-10-23 | — | — | US | claimed |
| US-20250326723-A1 | Development of an Enzyme-Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One-Pot Megamolecule Assembly | UNIV NORTHWESTERN (US) | 2025-10-23 | — | — | US | claimed |
| US-20250313531-A1 | Formulated and/or Co-Formulated Liposome Compositions Containing IDO Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof | NAMMI THERAPEUTICS, INC. | 2025-10-09 | — | — | US | claimed |
| US-20250282866-A1 | TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS | VIGIL NEUROSCIENCE INC (US) | 2025-09-11 | — | — | US | claimed |
| EP-4590349-A1 | SOLID AND COMPACT BIOMATERIAL, METHOD FOR ITS PREPARATION AND KIT FOR FILLING BONE CAVITIES | TECRES S.P.A. (IT) | 2025-07-30 | — | — | EP | claimed |
| US-20250236572-A1 | METHOD FOR SEPARATING METHANE USING HYDRATE | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-07-24 | — | — | US | claimed |
| EP-4581150-A1 | PREPARATION AND USE OF BLOCKED SUBSTRATES | Illumina, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| WO-2025101765-A9 | NOVEL LIVER-TARGETING GLUCOCORTICOID PRODRUGS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2025-06-19 | — | — | WO | claimed |
| CN-110602948-B | Microencapsulated nitrification inhibitor compositions | 美国陶氏益农公司 | 2022-04-01 | — | — | CN | claimed |
| WO-2022053659-A2 | HETEROCYCLIC COMPOUNDS USED AS NITRIFICATION INHIBITOR | EUROCHEM ANTWERPEN (BE) | 2022-03-17 | — | — | WO | claimed |
| WO-2022053660-A2 | N-HETEROCYCLIC COMPOUNDS USED AS NITRIFICATION INHIBITOR | EUROCHEM ANTWERPEN (BE) | 2022-03-17 | — | — | WO | claimed |
| WO-2022053661-A2 | PYRAZOLO[3,4-B]PYRIDINE-4-CARBOXAMIDE NITRIFICATION INHIBITOR | EUROCHEM ANTWERPEN (BE) | 2022-03-17 | — | — | WO | claimed |
| CN-114163275-A | Soil conditioner with balanced microorganisms and preparation method thereof | 中国科学院沈阳应用生态研究所 | 2022-03-11 | — | — | CN | claimed |
| CN-109415278-B | Compositions suitable for use in the preparation of fertilizers, methods of preparing these compositions, and methods of preparing fertilizers using the compositions | 美利肯公司 | 2022-02-22 | — | — | CN | claimed |
| WO-2022031843-A1 | METHODS OF CONTROLLING THE RIPENING OF AGRICULTURAL PRODUCTS | APEEL TECHNOLOGY, INC. (US) | 2022-02-10 | — | — | WO | claimed |
| WO-2022032293-A2 | TREATMENT OF DISEASES RELATED TO COLONY-STIMULATING FACTOR 1 RECEPTOR DYSFUNCTION USING TREM2 AGONISTS | VIGIL NEUROSCIENCE, INC. (US) | 2022-02-10 | — | — | WO | claimed |
| US-20220039416-A1 | METHODS OF CONTROLLING THE RIPENING OF AGRICULTURAL PRODUCTS | APEEL TECHNOLOGY, INC. | 2022-02-10 | — | — | US | claimed |
| CN-113999070-A | Alkaline soil conditioner and preparation method thereof | 中国科学院沈阳应用生态研究所 | 2022-02-01 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313531-A1 | Formulated and/or Co-Formulated Liposome Compositions Containing IDO Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof | IDO1, IDO2, KYNU | CYP3A4 2038/4885TSHR 4033/4885NFE2L2 3357/4885 |
| US-20250326723-A1 | Development of an Enzyme-Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One-Pot Megamolecule Assembly | CRABP2, RARB, RARA | CYP3A4 2954/4885TSHR 631/4885NFE2L2 1885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.